H.R. 3354 · 117th Congress
CHANGE Act of 2021
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 117th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
SánchezSponsor45 cosponsors · 36 D, 9 R
D
Barragán
TC
R
Cole
PD
D
DeFazio
MD
D
Doyle
VD
D
Demings
BF
R
Fitzpatrick
RG
D
Grijalva
GG
R
Grothman
WK
D
Keating
AK
R
Kinzinger
AK
D
Kuster
AL
D
Lowenthal
DL
R
LaHood
DM
D
Matsui
EN
D
Norton
MN
D
Newman
BP
R
Posey
TS
D
Suozzi
MS
D
Sherrill
HS
D
Stevens
FU
R
Upton
MW
D
Waters
PW
D
Welch
MT
D
Takano
GN
D
Napolitano
JR
D
Raskin
FV
D
Vela
TL
D
Leger Fernandez
JC
D
Chu
SW
D
Wild
CA
D
Axne
RK
D
Khanna
JM
D
McGovern
DP
D
Payne
AB
D
Brown
DB
R
Bacon
MD
D
Dean
DT
D
Titus
MP
D
Pocan
LR
D
Roybal-Allard
MS
R
Salazar
RT
D
Tlaib
JB
D
Beatty
DS
D
Scott
GS
D
Stanton23 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2021 or the CHANGE Act of 2021 This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults.
What it does: CRS summary · Introduced in House · May 19, 2021
Concentrating on High-value Alzheimer's Needs to Get to an End Act of 2021 or the CHANGE Act of 2021
This bill modifies the requirements under Medicare for diagnosing and treating Alzheimer's disease and other cognitive impairments in older adults. Specifically, the bill expands the cognitive impairment detection benefit during annual wellness visits to require the use of validated detection tools and documentation of the results in the patient's medical record. Further, when a cognitive impairment is detected, the patient must be referred to an appropriate diagnostic service provider and other specified supports.
Additionally, the Centers for Medicare & Medicaid Services must implement Medicare policies that increase the identification and response to patients' Alzheimer's disease risk factors and incentivize providers to utilize high-quality cognitive impairment diagnosis practices.
The Government Accountability Office also must conduct a study of policies that may accelerate progress in Alzheimer's disease research and enhance the quality of care for individuals diagnosed with Alzheimer's disease.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: CHANGE Act of 2021
Also known as: Concentrating on High-value Alzheimer’s Needs to Get to an End Act of 2021
Latest action (May 20, 2021): Referred to the Subcommittee on Health.
Policy area: Health · Origin: House · Introduced: May 19, 2021
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.